Page last updated: 2024-09-03

clofarabine and ter 199

clofarabine has been researched along with ter 199 in 2 studies

Compound Research Comparison

Studies (clofarabine)	Trials (clofarabine)	Recent Studies (post-2010) (clofarabine)	Studies (ter 199)	Trials (ter 199)	Recent Studies (post-2010) (ter 199)
424	101	280	21	4	8

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Steensma, DP	1
Jabbour, E; Kadia, TM; Kantarjian, H	1

Reviews

2 review(s) available for clofarabine and ter 199

Article	Year
Novel therapies for myelodysplastic syndromes. Hematology/oncology clinics of North America, 2010, Volume: 24, Issue:2 Topics: Adenine Nucleotides; Aged; Alkylating Agents; Antimetabolites; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; DNA Repair; Drug Therapy, Combination; Drugs, Investigational; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Glutathione; Histone Deacetylase Inhibitors; Humans; Hydrazines; JNK Mitogen-Activated Protein Kinases; Myelodysplastic Syndromes; Quinolones; Sulfonamides; Therapies, Investigational	2010
Failure of hypomethylating agent-based therapy in myelodysplastic syndromes. Seminars in oncology, 2011, Volume: 38, Issue:5 Topics: Adenine Nucleotides; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Clofarabine; Cytosine; Decitabine; Drug Resistance; Drug Substitution; Enzyme Inhibitors; Glutathione; Glycine; Humans; Myelodysplastic Syndromes; Stem Cell Transplantation; Sulfones; Treatment Failure	2011

Article

Year

Novel therapies for myelodysplastic syndromes.

Hematology/oncology clinics of North America, 2010, Volume: 24, Issue:2

Topics: Adenine Nucleotides; Aged; Alkylating Agents; Antimetabolites; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; DNA Repair; Drug Therapy, Combination; Drugs, Investigational; Enzyme Activation; Enzyme Inhibitors; Farnesyltranstransferase; Glutathione; Histone Deacetylase Inhibitors; Humans; Hydrazines; JNK Mitogen-Activated Protein Kinases; Myelodysplastic Syndromes; Quinolones; Sulfonamides; Therapies, Investigational

2010

Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.

Seminars in oncology, 2011, Volume: 38, Issue:5

Topics: Adenine Nucleotides; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Clofarabine; Cytosine; Decitabine; Drug Resistance; Drug Substitution; Enzyme Inhibitors; Glutathione; Glycine; Humans; Myelodysplastic Syndromes; Stem Cell Transplantation; Sulfones; Treatment Failure

2011